Telista Ch 40/6.25 Tablet 10

Telista-CH 40/6.25 Tablet is contraindicated during the second and third trimesters of pregnancy due to the risk of harm to the foetus. If you're pregnant or planning to conceive, it's important to discuss this with your doctor before starting this medicine.

Caution is advised on the use of Telista-CH 40/6.25 Tablet during breastfeeding. It's best to consult your doctor for advice on this matter.

Alcohol may enhance the blood pressure lowering effect of Telista-CH 40/6.25 Tablet, which could make you feel dizzy or faint. Caution is advised if you consume alcohol while taking this medicine.

If you have liver problems, caution is recommended when taking Telista-CH 40/6.25 Tablet. This medicine may affect liver function, so it's advisable to discuss any liver-related concerns with your doctor before starting treatment.

Telista-CH 40/6.25 Tablet is not recommended for patients with severe kidney impairment or those undergoing dialysis. If you have a history of kidney problems, it's wise to consult your doctor before starting this medication.

As Telista-CH 40/6.25 Tablet can cause dizziness, care should be taken when operating machinery or driving until you know how this medicine affects you.

If you're allergic to telmisartan, chlorthalidone or any other ingredients in Telista-CH 40/6.25 Tablet, avoid taking it and consult your doctor for alternative options.

The safety and efficacy of Telista-CH 40/6.25 Tablet have not been established in children under 18 years old. It is advisable to consult your doctor before giving this medicine to a child.

Older patients should take Telista-CH 40/6.25 Tablet under medical supervision as they may be more susceptible to its side effects. Caution is advised for patients above 70 years of age who might also have liver and kidney issues or might be on other medication. Your doctor will guide you based on your health status.